These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage? Roman A Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322 [No Abstract] [Full Text] [Related]
4. The Health Impact Fund: incentives for improving access to medicines. Banerjee A; Hollis A; Pogge T Lancet; 2010 Jan; 375(9709):166-9. PubMed ID: 20109894 [No Abstract] [Full Text] [Related]
5. Worldwide interest in global access to drugs. Banta HD JAMA; 2001 Jun; 285(22):2844-6. PubMed ID: 11401589 [No Abstract] [Full Text] [Related]
6. Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages. Seghers F; Taylor MM; Storey A; Dong J; Wi TC; Wyber R; Ralston K; Nguimfack BD Int Health; 2024 May; 16(3):279-282. PubMed ID: 37787149 [TBL] [Abstract][Full Text] [Related]
7. Pressure mounts on drug supplies in Greece. Photopoulos J BMJ; 2015 Jul; 351():h3804. PubMed ID: 26169533 [No Abstract] [Full Text] [Related]
8. Pharmaceutical forecasting: throwing darts? Cha M; Rifai B; Sarraf P Nat Rev Drug Discov; 2013 Oct; 12(10):737-8. PubMed ID: 24080692 [No Abstract] [Full Text] [Related]
9. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits. Burci GL; Gostin LO JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485 [No Abstract] [Full Text] [Related]
10. Pharmaceutical industry financial performance. Goodman M Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398 [No Abstract] [Full Text] [Related]
11. [The Brazilian pharmaceutical industry and foreign trade: is there evidence of regressive specialization?]. Mota FB; Cassiolato JE; Gadelha CA Cad Saude Publica; 2012 Mar; 28(3):527-36. PubMed ID: 22415185 [TBL] [Abstract][Full Text] [Related]
12. Availability of benzathine penicillin G for syphilis treatment in Shandong Province, Eastern China. Chen X; Li G; Gan Y; Chu T; Liu D BMC Health Serv Res; 2019 Mar; 19(1):188. PubMed ID: 30902053 [TBL] [Abstract][Full Text] [Related]
13. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
14. The ethics and economics of pharmaceutical pricing. Parker-Lue S; Santoro M; Koski G Annu Rev Pharmacol Toxicol; 2015; 55():191-206. PubMed ID: 25149920 [TBL] [Abstract][Full Text] [Related]
15. [The world population does not have the drugs it needs. WHO report recommends more stringent control of the drug industry]. Asplund K Lakartidningen; 2005 Feb 14-20; 102(7):450-1. PubMed ID: 15768693 [No Abstract] [Full Text] [Related]
16. Increase in global access to essential drugs sought. Banta D JAMA; 2000 Jan; 283(3):321, 323. PubMed ID: 10647785 [No Abstract] [Full Text] [Related]
17. Biomanufacturing, from bust to boom...to bubble? Thiel KA Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157 [No Abstract] [Full Text] [Related]
18. Drug patent plan gets mixed reviews. Butler D Nature; 2009 Feb; 457(7233):1064. PubMed ID: 19256077 [No Abstract] [Full Text] [Related]
19. Pharmaceuticals and medical devices: business practices. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-36. PubMed ID: 23297448 [No Abstract] [Full Text] [Related]
20. Research on green supply chain coordination strategy for uncertain market demand. Cao J; Chen Y; Lu B; Tong C; Zhou G Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):687-92. PubMed ID: 25796145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]